“Never let the fear of striking out get in your way”
- BA, Rice University
- Current Affiliation
- Social Media
Joel has been a CFO at various biotech companies, two of which went public under his watch: Spero and Forward Pharma. Most recently, he was CFO at Sema4. Adding in his time in business development at Progenics, Joel has over a decade of experience as a biotech executive. Joel also has 20 years of Wall Street experience, most notably as a senior analyst covering biotech at Stifel and Lazard, where he also led the overall healthcare equity research efforts and was ranked #1 overall in the Wall Street Journal’s Best on the Street survey. He started his career as an investment banker at Goldman Sachs. Joel graduated from Rice University, where he has a degree in biochemistry.